Financials
- Market Capitalization 626.74 M
- Employee 146
- Founded 2019
- CEO N/A
- Website www.primemedicine.com
- Headquarter Delaware, United States
- FIGI BBG011RT3R55
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.57
市销率
111.44
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2751 | ALLO Allogene Therapeutics, Inc. - Common Stock | 1.86 USD | -3.63% | -13.49% | -3.63% | +44.19% | 641.99 M USD | ||
| 2759 | ACHV Achieve Life Sciences, Inc. - Common Shares | 6.32 USD | +3.61% | -3.07% | +12.26% | +121.75% | 648.81 M USD | ||
| 2764 | RGNX REGENXBIO Inc. - Common Stock | 12.30 USD | -3.53% | -18.11% | +81.15% | -8.41% | 635.88 M USD | ||
| 2769 | GYRE Gyre Therapeutics, Inc. - Common Stock | 6.34 USD | 0.00% | -9.56% | +6.55% | -23.24% | 615.16 M USD |